Cite
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START) trial.
MLA
Soliman, Ez, et al. “Baseline Cardiovascular Risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START) Trial.” HIV Medicine, vol. 16, Apr. 2015, pp. 46–54. EBSCOhost, https://doi.org/10.1111/hiv.12233.
APA
Soliman, E., Sharma, S., Arastéh, K., Wohl, D., Achhra, A., Tambussi, G., O’Connor, J., Stein, J., Duprez, D., Neaton, J., & Phillips, A. (2015). Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START) trial. HIV Medicine, 16, 46–54. https://doi.org/10.1111/hiv.12233
Chicago
Soliman, Ez, S Sharma, K Arastéh, D Wohl, A Achhra, G Tambussi, J O’Connor, et al. 2015. “Baseline Cardiovascular Risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START) Trial.” HIV Medicine 16 (April): 46–54. doi:10.1111/hiv.12233.